The idea of a benefit from timely therapy for ED patients with heart failure has been inferred from treatment of acute myocardial infarction (AMI), but aspects of acute heart failure, including
Fondaparinux was associated with lower risk of major bleeding and death than low-molecular-weight heparin (LMWH) for patients with non-ST-segment elevation myocardial infarction (NSTEMI), a recent prospective study ... found. Fondaparinux was associated
The mortality benefit of using azithromycin in elderly inpatients with pneumonia outstrips a slightly higher risk of myocardial infarction associated with the drug, researchers have found. ... The net benefit is “around 7 deaths averted for 1 nonfatal
Also, with both 110-mg and 150-mg dabigatran doses, there was less intracranial bleeding (aHR, 0.24 and 0.08 respectively) and a lower incidence of myocardial infarction (aHR, ... The previous concerns about an excess of bleeding events or myocardial
More than 65% of patients who have a myocardial infarction (MI) within 30 days of noncardiac surgery don't experience ischemic symptoms, a new study found.
For example, according to Dr. Horwitz's study, between 2010 and 2012 the lowest-performing hospitals were proactive in addressing readmissions for the three initial target conditions—acute myocardial infarction, congestive
Prognostic value of acute-to-chronic glycemic ratio better than glycemia at admission for AMI patients
For patients with acute myocardial infarction (AMI), the acute-to-chronic (A/C) glycemic ratio predicts in-hospital morbidity and mortality better than glycemia at admission, according to a new study.
A nonsignificant trend toward decreased cardiac mortality was also seen in CR participants, though there was no observed effect for myocardial infarction or revascularization. ... It's well known that CR helps lower mortality rates after myocardial
CHAMPION-PCI and CHAMPION-PHOENIX enrolled patients with stable angina, non-ST-segment elevation acute coronary syndrome or ST-segment elevation myocardial infarction (STEMI), while CHAMPION-PHOENIX did not enroll patients ... All-cause death, myocardial
The decisions made by hospital staff in the first few minutes following an acute myocardial infarction (MI) often determine whether a patient lives or dies.